EMA Market Approval Rate for Small Biotechs Skyrocketed Last Year
The success rate for small biotechs applying for regulatory approval from the EMA has risen…
The success rate for small biotechs applying for regulatory approval from the EMA has risen…
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
The London-based life sciences investor 4BIO Capital has raised €45M in the first close of…
Orchard Therapeutics' gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than…
In less than two years, Orchard Therapeutics has changed from a small, relatively unknown UK…
Patients with the life-threatening blood disorder beta-thalassemia required fewer blood transfusions after receiving a gene…
A gene therapy developed by the UK company Orchard Therapeutics has greatly improved the motor…
All 20 patients with a rare immunodeficiency disease survived for at least two years after…
A single dose of a gene therapy developed by Orchard Therapeutics can restore immune function…
Orchard Therapeutics, a British company developing gene therapy for rare genetic diseases, has launched its…
Orchard Therapeutics raised $150M (€132M) in Series C financing to bring its gene therapies from…
Orchard Therapeutics has received a fourth Rare Pediatric Disease Designation from the FDA for its…